Form 4 for PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-02 · accession 0001299130-23-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-02 | PACB | Eidel Jeff | See Remarks | A - Grant | $0.00 | +164.2K | 470.6K | +54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | A | A | 164,200 | $0.00 | 470,602 | D | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date. (F2) Includes 5,832 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. |